Amylx Pharmaceuticals Inc vs Ross Stores, Inc. — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Ross Stores, Inc. trades at $251.3 (market cap $80.78B). The key difference: Ross Stores, Inc. is far larger — about 30.6× Amylx Pharmaceuticals Inc's market cap, and Ross Stores, Inc. pays a 0.71% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | ROST | |
|---|---|---|
Market Cap | $2.64B | $80.78B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $255.23 |
52-Week Low | $7.82 | $144.67 |
Enterprise Value | $2.39B | $81.37B |
Dividend Yield | — | 0.71% |
Trailing returns across standard periods
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →